# ImmunityBio, Inc. (IBRX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/IBRX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 44.21M | $ -632.78M | $ -77.15M | $ 1.12B | $ -870.01M |
| 2025 | $ 116.00M | $ -359.80M | $ -316.17M | $ 878.12M | $ -499.57M |
| 2024 | $ 15.50M | $ -434.69M | $ -418.46M | $ 504.17M | $ -489.10M |
| 2023 | $ 672.5K | $ -630.58M | $ -429.63M | $ 726.72M | $ -586.99M |
| 2022 | $ 268.1K | $ -465.35M | $ -464.35M | $ 723.77M | $ -447.33M |
| 2021 | $ 1.11M | $ -412.21M | $ -366.08M | $ 645.66M | $ -242.17M |
| 2020 | $ 984.7K | $ -237.22M | $ -220.89M | $ 275.55M | $ -119.81M |
| 2019 | $ 1.23M | $ -93.49M | $ -84.60M | $ 14.85M | $ 120.68M |
| 2018 | $ 62.1K | $ -127.08M | $ -101.01M | $ 6.91M | $ 146.01M |
| 2017 | $ 60.6K | $ -129.89M | $ -112.61M | $ 7.27M | $ 218.84M |
| 2016 | $ 60.5K | $ -166.18M | $ -62.12M | $ 8.21M | $ 293.42M |
| 2015 | $ 161.5K | $ -286.50M | $ -38.68M | $ 2.47M | $ 356.00M |
| 2014 | N/A | N/A | $ -7.99M | $ 265.0K | $ 58.42M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -1.29 |
| Liabilities / Eq | -1.74 |
| Current Ratio | 6.67 |

## Other views

- [Metrics](https://sponda.capital/en/IBRX.md)
- [Charts](https://sponda.capital/en/IBRX/charts.md)
- [Compare](https://sponda.capital/en/IBRX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.